交易 Harvard Bioscience - HBIO CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.1210 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Harvard Bioscience Inc ESG Risk Ratings
High Medium Low Negligible
“D”分數表示相對 ESG 表現較差,公開報告重要 ESG 數據的透明度不足。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Mar 27, 2024 | 4.1795 | 0.1000 | 2.45% | 4.0795 | 4.1895 | 3.9195 |
Mar 26, 2024 | 4.0195 | -0.0700 | -1.71% | 4.0895 | 4.1195 | 3.8895 |
Mar 25, 2024 | 4.1195 | -0.1900 | -4.41% | 4.3095 | 4.3095 | 4.0895 |
Mar 22, 2024 | 4.1795 | -0.1100 | -2.56% | 4.2895 | 4.2895 | 4.0395 |
Mar 21, 2024 | 4.3195 | 0.0500 | 1.17% | 4.2695 | 4.3995 | 4.2095 |
Mar 20, 2024 | 4.3695 | 0.1300 | 3.07% | 4.2395 | 4.3895 | 4.1795 |
Mar 19, 2024 | 4.3695 | 0.2700 | 6.59% | 4.0995 | 4.4095 | 4.0995 |
Mar 18, 2024 | 4.1395 | 0.1400 | 3.50% | 3.9995 | 4.2695 | 3.8295 |
Mar 15, 2024 | 4.0295 | -0.0600 | -1.47% | 4.0895 | 4.2595 | 3.9995 |
Mar 14, 2024 | 4.2495 | 0.0300 | 0.71% | 4.2195 | 4.3995 | 4.1895 |
Mar 13, 2024 | 4.3395 | 0.1500 | 3.58% | 4.1895 | 4.3495 | 4.1395 |
Mar 12, 2024 | 4.2595 | -0.0400 | -0.93% | 4.2995 | 4.3595 | 4.1895 |
Mar 11, 2024 | 4.3395 | 0.1100 | 2.60% | 4.2295 | 4.4795 | 4.1795 |
Mar 8, 2024 | 4.3995 | -0.1000 | -2.22% | 4.4995 | 4.5395 | 4.2995 |
Mar 7, 2024 | 4.4795 | 0.4600 | 11.44% | 4.0195 | 4.5395 | 3.9895 |
Mar 6, 2024 | 4.0595 | -0.2000 | -4.70% | 4.2595 | 4.2895 | 3.9895 |
Mar 5, 2024 | 4.1895 | -0.1500 | -3.46% | 4.3395 | 4.3395 | 4.1295 |
Mar 4, 2024 | 4.3295 | 0.0400 | 0.93% | 4.2895 | 4.4095 | 4.2895 |
Mar 1, 2024 | 4.3395 | 0.0900 | 2.12% | 4.2495 | 4.3595 | 4.2295 |
Feb 29, 2024 | 4.2995 | -0.0700 | -1.60% | 4.3695 | 4.4095 | 4.2295 |
Harvard Bioscience Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Tuesday, April 23, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 Harvard Bioscience Inc Earnings Release Q1 2024 Harvard Bioscience Inc Earnings ReleaseForecast(預報) -返回 - |
Tuesday, May 14, 2024 | ||
時間 (UTC) 15:00 | 國家 US
| 事件 Harvard Bioscience Inc Annual Shareholders Meeting Harvard Bioscience Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 113.335 | 118.904 | 102.1 | 116.176 | 120.774 |
收入 | 113.335 | 118.904 | 102.1 | 116.176 | 120.774 |
收入成本,共計 | 51.045 | 51.252 | 44.059 | 51.654 | 53.793 |
毛利 | 62.29 | 67.652 | 58.041 | 64.522 | 66.981 |
總營業費用 | 120.268 | 116.838 | 103.755 | 115.799 | 123.19 |
銷售/一般/行政費用,總計 | 48.611 | 47.672 | 43.425 | 45.324 | 45.825 |
研究與開發 | 12.329 | 10.799 | 8.685 | 10.715 | 10.988 |
Depreciation / Amortization | 6.122 | 5.84 | 5.71 | 5.746 | 5.384 |
異常費用(收入) | 2.161 | 1.275 | 1.876 | 2.36 | 7.2 |
營業收入 | -6.933 | 2.066 | -1.655 | 0.377 | -2.416 |
利息收入(費用),非經營淨值 | -2.548 | -1.54 | -4.831 | -5.41 | -5.219 |
其他,淨值 | 0.302 | -0.666 | -0.806 | -0.469 | -0.34 |
稅前淨收入 | -9.179 | -0.14 | -7.292 | -5.502 | -7.975 |
稅後淨收入 | -9.516 | -0.288 | -7.81 | -4.687 | -4.299 |
未計算非常項目前的淨收益 | -9.516 | -0.288 | -7.81 | -4.687 | -4.299 |
淨收入 | -9.516 | -0.288 | -7.81 | -4.687 | -2.922 |
普通股股東可獲收益 (不含非經常性項目) | -9.516 | -0.288 | -7.81 | -4.687 | -4.299 |
普通股股東可獲收益 (含非經常性項目) | -9.516 | -0.288 | -7.81 | -4.687 | -2.922 |
攤薄淨收入 | -9.516 | -0.288 | -7.81 | -4.687 | -2.922 |
攤薄後加權平均股 | 41.413 | 40.343 | 38.64 | 37.814 | 36.453 |
扣除特別項目的每股攤薄盈利 | -0.22978 | -0.00714 | -0.20212 | -0.12395 | -0.11793 |
每股正常攤薄盈利 | -0.19586 | 0.0134 | -0.13637 | -0.08338 | 0.01045 |
非常規項目總計 | 0 | 1.377 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 28.759 | 29.975 | 28.427 | 26.922 | 29.208 |
收入 | 28.759 | 29.975 | 28.427 | 26.922 | 29.208 |
收入成本,共計 | 12.086 | 11.629 | 12.594 | 14.75 | 12.571 |
毛利 | 16.673 | 18.346 | 15.833 | 12.172 | 16.637 |
總營業費用 | 27.963 | 28.226 | 28.884 | 30.684 | 25.21 |
銷售/一般/行政費用,總計 | 11.531 | 12.312 | 11.811 | 12.143 | 12.568 |
研究與開發 | 2.957 | 2.897 | 2.849 | 2.763 | 3.497 |
Depreciation / Amortization | 1.389 | 1.388 | 1.63 | 1.572 | 1.454 |
異常費用(收入) | 0 | 0 | 0 | -0.544 | -4.88 |
營業收入 | 0.796 | 1.749 | -0.457 | -3.762 | 3.998 |
利息收入(費用),非經營淨值 | -2.522 | -0.974 | -0.9 | -0.749 | -0.515 |
其他,淨值 | -0.372 | 0.432 | 0.465 | -0.179 | -0.062 |
稅前淨收入 | -2.098 | 1.207 | -0.892 | -4.69 | 3.421 |
稅後淨收入 | -0.98 | 0.622 | -1.666 | -3.405 | 2.435 |
未計算非常項目前的淨收益 | -0.98 | 0.622 | -1.666 | -3.405 | 2.435 |
淨收入 | -0.98 | 0.622 | -1.666 | -3.405 | 2.435 |
普通股股東可獲收益 (不含非經常性項目) | -0.98 | 0.622 | -1.666 | -3.405 | 2.435 |
普通股股東可獲收益 (含非經常性項目) | -0.98 | 0.622 | -1.666 | -3.405 | 2.435 |
攤薄淨收入 | -0.98 | 0.622 | -1.666 | -3.405 | 2.435 |
攤薄後加權平均股 | 42.354 | 42.783 | 41.593 | 41.637 | 42.56 |
扣除特別項目的每股攤薄盈利 | -0.02314 | 0.01454 | -0.04005 | -0.08178 | 0.05721 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.02314 | 0.01454 | -0.04005 | -0.09027 | -0.01732 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 51.124 | 61.583 | 51.7 | 53.572 | 57.832 |
現金和短期投資 | 4.508 | 7.821 | 8.317 | 8.335 | 8.173 |
現金等價物 | 4.508 | 7.821 | 8.317 | 8.335 | 8.173 |
應收賬款總額,淨額 | 20.177 | 26.175 | 21.121 | 23.176 | 24.572 |
應收賬款 - 貿易,淨額 | 16.705 | 21.834 | 17.766 | 20.704 | 21.463 |
總庫存 | 26.439 | 27.587 | 22.262 | 22.061 | 25.087 |
其他流動資産,總計 | |||||
總資産 | 145.36 | 162.344 | 156.254 | 164.87 | 168.613 |
物業/廠房/設備,總計 - 淨額 | 9.182 | 10.312 | 11.721 | 13.239 | 5.898 |
物業/廠房/設備,總計 - 總額 | 24.028 | 24.761 | 28.318 | 28.179 | 23.336 |
累計折舊,總計 | -14.846 | -14.449 | -16.597 | -14.94 | -17.438 |
商譽,淨額 | 56.26 | 57.689 | 58.59 | 57.381 | 57.304 |
無形資産,淨額 | 21.014 | 27.385 | 33.151 | 38.405 | 45.764 |
其他長期資産,總計 | 7.78 | 5.375 | 1.092 | 2.273 | 1.815 |
流動負債總額 | 23.249 | 25.316 | 21.053 | 25.312 | 25.489 |
應付賬款 | 6.447 | 4.911 | 5.972 | 5.339 | 7.359 |
預提費用 | 8.639 | 11.175 | 7.582 | 2.424 | 5.762 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 3.811 | 3.235 | 1.721 | 6.9 | 5.982 |
其他流動負債,總計 | 4.352 | 5.995 | 5.778 | 10.649 | 6.386 |
負債總額 | 73.14 | 78.943 | 79.573 | 83.176 | 85.889 |
長期債務總額 | 43.013 | 45.095 | 46.286 | 46.917 | 54.813 |
長期債務 | 43.013 | 45.095 | 46.286 | 46.917 | 54.813 |
遞延所得稅 | 0.59 | 1.558 | 1.899 | 1.974 | 2.301 |
其他負債,總計 | 6.288 | 6.974 | 10.335 | 8.973 | 3.286 |
股權 | 72.22 | 83.401 | 76.681 | 81.694 | 82.724 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
普通股 | 0.454 | 0.452 | 0.444 | 0.438 | 0.436 |
額外實收資本 | 229.008 | 225.65 | 232.357 | 229.189 | 226.377 |
留存收益(累計赤字) | -142.19 | -132.674 | -132.386 | -124.576 | -119.889 |
Treasury Stock - Common | 0 | -10.668 | -10.668 | -10.668 | |
其他權益,總計 | -15.052 | -10.027 | -13.066 | -12.689 | -13.532 |
總負債和股東權益 | 145.36 | 162.344 | 156.254 | 164.87 | 168.613 |
已發行普通股總數 | 42.0817 | 41.1429 | 39.4071 | 38.1882 | 37.3788 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 50.486 | 52.617 | 52.449 | 51.124 | 51.818 |
現金和短期投資 | 5.34 | 4.324 | 3.789 | 4.508 | 5.144 |
現金等價物 | 5.34 | 4.324 | 3.789 | 4.508 | 5.144 |
應收賬款總額,淨額 | 19.328 | 22.204 | 21.799 | 20.177 | 20.558 |
應收賬款 - 貿易,淨額 | 14.983 | 16.903 | 17.737 | 16.705 | 15.023 |
總庫存 | 25.818 | 26.089 | 26.861 | 26.439 | 26.116 |
總資産 | 139.735 | 142.899 | 145.578 | 145.36 | 147.013 |
物業/廠房/設備,總計 - 淨額 | 8.419 | 8.744 | 8.929 | 9.182 | 9.574 |
商譽,淨額 | 56.222 | 56.771 | 56.618 | 56.26 | 54.851 |
無形資産,淨額 | 17.095 | 18.356 | 19.641 | 21.014 | 22.464 |
其他長期資産,總計 | 7.513 | 6.411 | 7.941 | 7.78 | 8.306 |
流動負債總額 | 24.205 | 22.942 | 23.217 | 23.249 | 21.36 |
應付賬款 | 6.269 | 4.716 | 5.978 | 6.447 | 5.877 |
預提費用 | 9.516 | 9.438 | 8.356 | 8.639 | 8.165 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 3.47 | 3.22 | 2.97 | 3.811 | 2.72 |
其他流動負債,總計 | 4.95 | 5.568 | 5.913 | 4.352 | 4.598 |
負債總額 | 65.449 | 67.511 | 71.238 | 73.14 | 75.034 |
長期債務總額 | 35.273 | 38.203 | 41.083 | 43.013 | 46.534 |
長期債務 | 35.273 | 38.203 | 41.083 | 43.013 | 46.534 |
遞延所得稅 | 0.661 | 0.667 | 0.546 | 0.59 | 1.181 |
其他負債,總計 | 5.31 | 5.699 | 6.392 | 6.288 | 5.959 |
股權 | 74.286 | 75.388 | 74.34 | 72.22 | 71.979 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
普通股 | 0.457 | 0.457 | 0.455 | 0.454 | 0.453 |
額外實收資本 | 232.896 | 231.533 | 230.108 | 229.008 | 228.229 |
留存收益(累計赤字) | -143.787 | -142.548 | -141.568 | -142.19 | -140.524 |
Treasury Stock - Common | |||||
其他權益,總計 | -15.28 | -14.054 | -14.655 | -15.052 | -16.179 |
總負債和股東權益 | 139.735 | 142.899 | 145.578 | 145.36 | 147.013 |
已發行普通股總數 | 42.6883 | 42.6883 | 42.19 | 42.0817 | 41.6577 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -9.516 | -0.288 | -7.81 | -4.687 | -2.922 |
經營活動産生的現金 | 1.152 | 1.262 | 9.331 | 8.045 | 2.884 |
經營活動産生的現金 | 1.453 | 1.781 | 1.922 | 1.987 | 2.423 |
Amortization | 6.122 | 5.84 | 5.71 | 5.746 | 5.459 |
Deferred Taxes | -0.414 | -0.33 | -0.143 | -0.398 | -2.861 |
非現金物品 | 0.791 | 4.449 | 5.546 | 5.355 | 2.46 |
Cash Taxes Paid | 0.534 | 0.577 | 0.416 | 0.374 | -0.098 |
已付現金利息 | 2.314 | 1.577 | 4.881 | 5.496 | 4.987 |
營運資金的變化 | 2.716 | -10.19 | 4.106 | 0.042 | -1.675 |
投資活動産生的現金 | -1.59 | -1.345 | -1.402 | -0.229 | -53.796 |
資本支出 | -1.59 | -1.345 | -1.152 | -1.216 | -1.006 |
其他投資現金流量項目,總計 | -0.25 | 0.987 | -52.79 | ||
融資活動産生的現金 | -2.837 | -0.252 | -7.967 | -7.624 | 53.053 |
股票的發行(報廢),淨額 | 0.577 | 3.314 | 4.557 | ||
債務的發行(退還),淨額 | -1.786 | 0.05 | -5.597 | -7.403 | 48.496 |
外彙效應 | -0.038 | -0.161 | 0.02 | -0.03 | 0.299 |
現金淨變化 | -3.313 | -0.496 | -0.018 | 0.162 | 2.44 |
融資現金流項目 | -1.628 | -3.616 | -2.37 | -0.221 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 0.622 | -9.516 | -7.85 | -4.445 | -6.88 |
Cash From Operating Activities | 1.812 | 1.152 | -1.527 | -2.176 | -1.986 |
Cash From Operating Activities | 0.333 | 1.453 | 1.122 | 0.758 | 0.382 |
Amortization | 1.388 | 6.122 | 4.492 | 2.92 | 1.466 |
Non-Cash Items | 0.765 | 0.791 | -0.289 | -1.498 | 0.97 |
Cash Taxes Paid | -0.134 | 0.534 | 0.493 | 0.352 | 0.107 |
Cash Interest Paid | 1.172 | 2.314 | 1.529 | 0.845 | 0.383 |
Changes in Working Capital | -1.296 | 2.716 | 1.158 | -0.951 | 2.076 |
Cash From Investing Activities | 0.288 | -1.59 | -1.355 | -0.913 | -0.471 |
Capital Expenditures | -0.224 | -1.59 | -1.355 | -0.913 | -0.471 |
Cash From Financing Activities | -2.893 | -2.837 | -0.107 | -0.484 | 0.094 |
Financing Cash Flow Items | -0.156 | -1.628 | -1.167 | -0.78 | -0.501 |
Issuance (Retirement) of Stock, Net | 0.104 | 0.577 | 0.346 | 0.282 | 0.031 |
Issuance (Retirement) of Debt, Net | -2.841 | -1.786 | 0.714 | 0.014 | 0.564 |
Foreign Exchange Effects | 0.074 | -0.038 | 0.312 | 0.011 | -0.025 |
Net Change in Cash | -0.719 | -3.313 | -2.677 | -3.562 | -2.388 |
Deferred Taxes | -0.414 | -0.16 | 1.04 | ||
Other Investing Cash Flow Items, Total | 0.512 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Advanced Medical Equipment & Technology (NEC) |
84 October Hill Rd
HOLLISTON
MASSACHUSETTS 01746-1371
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 580.000 多名交易者,選擇與 Capital.com 交易